by Jessica Casebolt | Jul 16, 2024 | Payers, Tea Leaves
A House committee overwhelmingly passed four bills on Thursday that would expand Medicare coverage of obesity drugs and cancer screening blood tests and place guardrails around Medicare’s discretion in covering drugs and devices approved by the Food and Drug...
by Jessica Casebolt | Jul 16, 2024 | Opioid/Substance Use Disorders, Tea Leaves
The Supreme Court decisively rejected Purdue Pharma’s bankruptcy reorganization plan that aimed to shield the Sackler family from lawsuits related to the opioid crisis. The 5-4 decision sided with arguments that the Sacklers abused the bankruptcy process to...
by Jessica Casebolt | Jul 16, 2024 | Providers, Tea Leaves
For-profit hospitals received lower marks on “socially responsible” metrics compared to nonprofits in an annual index from the Lown Institute released on Tuesday. For-profit hospitals were overrepresented in the lowest quality rankings on the index, which measured...
by Jessica Casebolt | Jul 16, 2024 | Payers, Tea Leaves
Employee health care costs are increasingly eating up larger shares of payroll costs for America’s smallest businesses, according to a new analysis from the JPMorgan Chase Institute. The pain of health care costs is nothing new, but this analysis, based on...
by Jessica Casebolt | Jul 16, 2024 | Life Sciences, Tea Leaves
A recent report indicates that while shortages of chemotherapy drugs like cisplatin and carboplatin have eased in the United States, concerns persist among major cancer centers regarding ongoing supply issues. According to a survey released by the National...
Recent Comments